| Lojuxta 10 mg hard capsules EU/1/13/851/002 |
Lomitapide mesylate |
Chiesi Farmaceutici S.p.A. |
— |
| Lojuxta 20 mg hard capsules EU/1/13/851/003 |
Lomitapide mesylate |
Chiesi Farmaceutici S.p.A. |
— |
| Lojuxta 30 mg hard capsules EU/1/13/851/004 |
Lomitapide mesylate |
Chiesi Farmaceutici S.p.A. |
— |
| Lojuxta 40 mg hard capsules EU/1/13/851/005 |
Lomitapide mesylate |
Chiesi Farmaceutici S.p.A. |
— |
| Lojuxta 5 mg hard capsules EU/1/13/851/001 |
Lomitapide mesylate |
Chiesi Farmaceutici S.p.A. |
— |
| Lojuxta 60 mg hard capsules EU/1/13/851/006 |
Lomitapide mesylate |
Chiesi Farmaceutici S.p.A. |
— |
| Lokelma 10 g powder for oral suspension EU/1/17/1173/003-004 |
Sodium zirconium cyclosilicate |
AstraZeneca AB |
— |
| Lokelma 5 g powder for oral suspension EU/1/17/1173/001-002 |
Sodium zirconium cyclosilicate |
AstraZeneca AB |
— |
| Lomexin 2% w/v Cutaneous Spray, Solution PA0812/002/005 |
Fenticonazole nitrate |
Recordati Industria Chimica e Farmaceutica SpA |
Not marketed |
| Lomexin 2% w/w Cream PA0812/002/001 |
Fenticonazole nitrate |
Recordati Industria Chimica e Farmaceutica SpA |
Not marketed |
| Lonquex 6 mg solution for injection in pre-filled syringe EU/1/13/856/001-002 |
Xm22 drug substance lipegfilgrastim |
Teva B.V. |
— |
| Lonquex 6 mg/0.6 ml solution for injection EU/1/13/856/005 |
lipegfilgrastim |
Teva B.V. |
— |
| Lonquex 6 mg/0.6 ml solution for injection EU/1/13/856/004 |
lipegfilgrastim |
Teva B.V. |
— |
| Lonsurf 15 mg/6.14 mg film-coated tablets EU/1/16/1096/001-003 |
Trifluridine |
Les Laboratoires Servier |
— |
| Lonsurf 20 mg/8.19 mg film-coated tablets EU/1/16/1096/004-006 |
Trifluridine |
Les Laboratoires Servier |
— |
| Lopinavir/Ritonavir Viatris 100 mg/25 mg film-coated tablets EU/1/15/1067/001-003 |
Lopinavir, Ritonavir |
Viatris Limited |
— |
| Lopinavir/Ritonavir Viatris 200 mg/50 mg film-coated tablets EU/1/15/1067/004-008 |
Lopinavir, Ritonavir |
Viatris Limited |
— |
| LOQTORZI 240 mg concentrate for solution for infusion EU/1/24/1853/001 |
Toripalimab |
Topalliance Biosciences Europe Limited |
— |
| Loratadine 10 mg Tablets PA22871/008/001 |
Loratadine |
Azure Pharmaceuticals Ltd. |
Marketed |
| Lorviqua 100 mg film-coated tablet EU/1/19/1355/002 |
LORLATINIB |
Pfizer Europe MA EEIG |
— |
| Lorviqua 25 mg film-coated tablets EU/1/19/1355/001 |
LORLATINIB |
Pfizer Europe MA EEIG |
— |
| Losartan Rowa 100mg film-coated tablets PA0074/082/003 |
Losartan potassium |
Rowa Pharmaceuticals Limited, |
Marketed |
| Losartan Rowa 50mg film-coated tablets PA0074/082/002 |
Losartan potassium |
Rowa Pharmaceuticals Limited, |
Marketed |
| Lotanos Comp 100 mg/25 mg film-coated tablets PA0074/072/002 |
Losartan potassium, Hydrochlorothiazide |
Rowa Pharmaceuticals Limited, |
Marketed |
| Lotanos Comp 50 mg/12.5 mg film-coated tablets PA0074/072/001 |
Losartan potassium, Hydrochlorothiazide |
Rowa Pharmaceuticals Limited, |
Marketed |
| Lubion 25 mg solution for injection in pre-filled syringe PA1104/006/001 |
Progesterone |
IBSA Farmaceutici Italia S.r.l |
Marketed |
| Lucentis 10 mg/ml solution for injection EU/1/06/374/002-004 |
Ranibizumab |
Novartis Europharm Limited |
— |
| Lumeblue 25 mg prolonged-release tablets EU/1/20/1470/001 |
Methylthioninium chloride |
Alfasigma S.p.A |
— |
| Lumigan 0.1 mg/ml eye drops, solution EU/1/02/205/3-4 |
Bimatoprost |
AbbVie Deutschland GmbH & Co. KG |
— |
| Lumigan 0.3 mg/ml eye drops, solution EU/1/02/205/001-2 |
Bimatoprost |
AbbVie Deutschland GmbH & Co. KG |
— |
| Luminity 150 microlitres/ml gas and solvent for dispersion for injection/infusion EU/1/06/361/01-2 |
Perflutren |
Lantheus EU Limited |
— |
| LUMYKRAS 120 mg film-coated tablets EU/1/21/1603/001-003 |
Sotorasib |
Amgen Europe B.V., |
— |
| LUMYKRAS 240 mg film-coated tablets EU/1/21/1603/004 |
Sotorasib |
Amgen Europe B.V., |
— |
| Lunsumio 1 mg concentrate for solution for infusion EU/1/22/1649/001 |
Mosunetuzumab |
Roche Registration GmbH |
— |
| Lunsumio 30 mg concentrate for solution for infusion EU/1/22/1649/002 |
Mosunetuzumab |
Roche Registration GmbH |
— |
| Lunsumio 45 mg solution for injection EU/1/22/1649/004 |
Mosunetuzumab |
Roche Registration GmbH |
— |
| Lunsumio 5 mg solution for injection EU/1/22/1649/003 |
Mosunetuzumab |
Roche Registration GmbH |
— |
| Lupkynis 7.9 mg soft capsules EU/1/22/1678/001 |
Voclosporin |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Lutathera 370 MBq/mL solution for infusion EU/1/17/1226/001 |
177lu-dotao-tyr3-octeeotate |
Advanced Accelerator Applications |
— |
| Lutetium (177Lu) chloride Billev 51.8 GBq/mL radiopharmaceutical precursor, solution EU/1/22/1680/001-006 |
Lutetium (177lu) chloride |
Billev Pharma ApS |
— |
| Luveris EU/1/00/155/001 |
Lutropin alfa |
Merck Europe B.V. |
— |
| Luveris EU/1/00/155/002 |
Lutropin alfa |
Merck Europe B.V. |
— |
| Luveris EU/1/00/155/003 |
Lutropin alfa |
Merck Europe B.V. |
— |
| Luveris EU/1/00/155/007 |
Lutropin alfa |
Merck Europe B.V. |
— |
| Luveris 75 IU powder and solvent for solution for injection EU/1/00/155/004 |
Lutropin alfa |
Merck Europe B.V. |
— |
| Luveris 75 IU powder and solvent for solution for injection EU/1/00/155/005 |
Lutropin alfa |
Merck Europe B.V. |
— |
| Luveris 75 IU powder and solvent for solution for injection EU/1/00/155/006 |
Lutropin alfa |
Merck Europe B.V. |
— |
| Luxturna 5 × 1012 vector genomes/mL concentrate and solvent for solution for injection EU/1/18/1331/001 |
VORETIGENE NEPARVOVEC |
Novartis Ireland Limited |
— |
| Lydisilka 3 mg/14.2 mg film-coated tablets EU/1/21/1548/001-004 |
Estetrol monohydrate, Estetrol, Drospirenone |
Estetra |
— |
| LYFNUA 45 mg Film-coated tablet EU/1/21/1613/001-004 |
Gefapixant |
Merck Sharp & Dohme BV, |
— |